Mode
Text Size
Log in / Sign up

Red blood cell parameters predict sepsis in children with ALL and chemotherapy-induced neutropeniaA Simple Blood Test Could Warn of Sepsis in Children on Chemotherapy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that RDW and pSOFA scores associate with sepsis in children with ALL and chemotherapy-induced neutropenia.

This retrospective cohort study examined children with acute lymphoblastic leukemia who received induction remission chemotherapy according to the South China Children's Leukemia Group-ALL-2016 protocol and subsequently developed chemotherapy-induced neutropenia. The initial sample included 264 patients, reduced to 108 after propensity score matching, comprising 75 in the chemotherapy-induced neutropenia (CIN) group and 33 in the sepsis group. Data were collected from the Affiliated Hospital of Guangdong Medical University and Huizhou Central People's Hospital.

The study assessed the predictive efficacy of red blood cell parameters, specifically hemoglobin and red blood cell distribution width (RDW), and their combined model. Comparisons were made between the CIN group and the sepsis group. Analysis revealed that RDW levels and pSOFA scores were significantly higher in the sepsis group compared to the CIN group, with a P value less than 0.05. Conversely, hemoglobin, red blood cell count, and hematocrit levels were significantly lower in the sepsis group.

No safety data, adverse events, or discontinuations were reported in this study. The primary limitation is the retrospective design, although propensity score matching was utilized to address confounding bias. The study did not report funding sources or potential conflicts of interest. While these RBC parameters show statistical associations with sepsis in this specific population, the observational nature of the research precludes establishing causation. Clinicians should interpret these results as indicators of potential risk rather than definitive diagnostic tools.

Imagine your child is fighting leukemia. The chemotherapy is working, but it has wiped out their infection-fighting white blood cells. Now, they spike a fever. Is it a minor bug or the start of a life-threatening bloodstream infection called sepsis? Doctors are racing the clock to figure it out.

A new study suggests the answer might already be hiding in a routine blood test.

Sepsis is the body’s extreme reaction to an infection. It can shut down organs. It moves fast. For any child, it’s an emergency.

For children with acute lymphoblastic leukemia (ALL), the most common childhood cancer, the risk is even higher. Their chemotherapy often causes a side effect called chemotherapy-induced neutropenia (CIN). This means their neutrophil count, a crucial type of white blood cell, crashes.

Without these soldiers, their body can’t fight invaders. A simple fever can be the first sign of a hidden, raging infection. Doctors must act quickly, often giving powerful antibiotics before they even know what they’re fighting.

The current tools to predict who will develop sepsis aren’t perfect. They can be complex or slow. Finding a faster, simpler warning sign could save lives.

The Surprising Shift

Doctors have always focused on white blood cells to gauge infection risk. That makes perfect sense. But what if other parts of the blood are telling an important story?

This research turned the spotlight away from white cells and onto red blood cells. Specifically, two common measurements: hemoglobin (which carries oxygen) and red blood cell distribution width (RDW).

RDW is a simple number that shows how much the size of a person’s red blood cells varies. Normally, they’re fairly uniform. A high RDW means there’s a big mix of large and small cells.

Scientists wondered if these everyday red blood cell clues could predict sepsis before it becomes obvious.

How It Works: The Body’s Distress Signal

Think of your bloodstream as a busy highway. Red blood cells are the trucks delivering oxygen. White blood cells are the police patrols.

During a massive infection like sepsis, the body goes into crisis mode. This intense inflammation can damage the highway itself and disrupt the truck factory (the bone marrow). New red blood cells come out in odd shapes and sizes. This shows up as a high RDW.

At the same time, the body may struggle to make enough trucks, leading to lower hemoglobin. So, even though the infection is fought by the police (white cells), the state of the trucks (red cells) reveals how severe the crisis is.

Researchers in China looked back at the records of 264 children with ALL who developed low white blood cell counts from chemo. They compared 33 who got sepsis to 75 who did not, carefully matching the children to make the groups as similar as possible.

They then checked if red blood cell measurements taken at the time of fever differed between the two groups.

The difference was clear. Children who developed sepsis had significantly higher RDW and lower hemoglobin levels than those who did not.

When combined into a simple model, these two red blood cell measures were good at identifying sepsis risk. The model worked better than looking at either measure alone.

The higher the RDW, the higher the risk. Children with the highest RDW levels had a much greater cumulative incidence of sepsis.

But here’s the catch. This doesn’t mean every hospital will start using RDW as a sepsis alarm tomorrow.

This study offers a practical and potentially powerful insight. RDW is already reported on every standard complete blood count (CBC) test. It’s cheap, fast, and universally available. Using it as an extra warning flag requires no new equipment, just new awareness.

It could help doctors triage which feverish, vulnerable child needs the most urgent, aggressive care.

If your child is undergoing chemotherapy, this is not a test you need to ask for. The RDW is already part of their frequent blood work. The change would be in how doctors interpret that number.

Right now, this is a research finding. It shows a strong association. The next step is for more studies to confirm if using RDW this way actually improves outcomes. Talk to your child’s oncologist about their protocol for monitoring fever and infection risk.

The Study's Limits

This was a retrospective study, meaning it looked back at old data. That can only show a link, not prove cause and effect. The number of children with sepsis in the study was also relatively small. The research needs to be repeated in larger, forward-looking trials.

The promise of this finding is its simplicity. The path forward involves validating it in bigger groups of children across different hospitals. Researchers will need to pinpoint the exact RDW threshold that should trigger the highest alert.

If confirmed, this could be a swift and seamless upgrade to pediatric cancer care—turning a humble, overlooked number on a common lab report into a lifeline.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo investigate the predictive efficacy and clinical application value of red blood cell (RBC) parameters (hemoglobin and red blood cell distribution width) and their combined model for sepsis during chemotherapy-induced neutropenia (CIN) in children with acute lymphoblastic leukemia (ALL), based on propensity score matching (PSM) to eliminate confounding bias between groups.MethodsA retrospective cohort design was adopted. A total of 264 children with ALL who received induction remission chemotherapy according to the South China Children's Leukemia Group-ALL-2016 (SCCLG-ALL-2016) protocol and developed CIN between January 2021 and December 2024 in the Affiliated Hospital of Guangdong Medical University and Huizhou Central People's Hospital were included. The patients were divided into a sepsis group and a CIN group according to clinical outcomes. PSM was used to balance baseline characteristics between groups. Univariate and multivariate logistic regression models were used to screen independent influencing factors for sepsis. Receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to evaluate the predictive efficacy and incremental value of single indicators and the combined model. Decision curve analysis (DCA) was applied to assess clinical net benefit, and Kaplan–Meier curves were plotted to analyze the cumulative incidence of sepsis under different RDW quartiles.ResultsA total of 108 patients were included after PSM matching (75 in the CIN group and 33 in the sepsis group). The RDW levels and pediatric Sequential Organ Failure Assessment (pSOFA) scores in the sepsis group were significantly higher than those in the CIN group, while Hb, RBC, and Hct levels were significantly lower (P 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.